Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis

.

Source: Amyloid: The Journal of Protein Folding Disorders - May 14, 2020 Category: Biochemistry Authors: Oliver C. Cohen Maximillian H. Brodermann Iona J. Blakeney Shameem Mahmood Sajitha Sachchithanantham Sriram Ravichandran Steven Law Helen J. Lachmann Carol J. Whelan Rakesh Popat Neil Rabin Kwee Yong Charalampia Kyriakou Raakhee Shah Simon Cheesman Sar Source Type: research